Biodesix to buy U.S. lab, lung nodule test from Oncimmune
The deal, which would become effective Nov. 1, is valued at up to $28 million over the next five years. Biodesix will acquire the UK company's US lab in Kansas.
The deal, which would become effective Nov. 1, is valued at up to $28 million over the next five years. Biodesix will acquire the UK company's US lab in Kansas.